Target intelligence / Profile preview

Microcirculatory disturbance (None)

Target
None
Molecular classification
Other (not a molecule or receptor; refers to a physiological/pathological state)
01

Overview

Microcirculatory disturbance refers to pathological changes or dysfunction within the smallest blood vessels—arterioles, capillaries, venules—collectively known as the microvasculature. These disturbances impair tissue perfusion and oxygen/nutrient delivery at the cellular level. Causes include endothelial cell damage (as seen in sepsis), increased vascular permeability leading to edema, inflammatory responses with cytokine release and leukocyte activation, formation of microthrombi obstructing blood flow, trauma-induced injury of vessel walls or pericytes/smooth muscle cells regulating tone. Clinically significant consequences range from local tissue hypoxia and organ dysfunction up to multi-organ failure if uncorrected. Microcirculatory disturbances are implicated in cardiovascular diseases (such as coronary microvascular angina), diabetes complications due to impaired capillary function/structure, severe infections like septic shock, chronic inflammation states, and other systemic illnesses. Note: "Microcirculatory disturbance" is not a specific molecular target but rather describes a pathophysiological process involving multiple cell types and mechanisms within the vascular system.

Other names
Microcirculatory disordermicrovascular dysfunctionmicrocirculation disorderpoor microcirculation
02

Mechanism of action

Not applicable to this entry; see above for general therapeutic approaches.

03

Biological functions

Tissue perfusionOxygen and nutrient deliveryWaste removalBlood flow regulationImmune response
04

Disease associations

Cardiovascular disease (including coronary artery disease, heart failure)Sepsis and septic shockDiabetes mellitus complicationsInflammation-related organ dysfunction
05

Safety considerations

Failure to address underlying causes can lead to multi-organ failure in critical illness (e.g., sepsis)
06

Interacting drugs

Vasodilators

4 more in the full profile.

07

Biomarkers

Reduced capillary density or perfusion (e.g., measured by imaging)Decreased coronary flow reserve (CFR)

Beyond the preview

Go deeper on Microcirculatory disturbance (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microcirculatory disturbance (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call